These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28683198)

  • 61. DOTAGA-trastuzumab. A new antibody conjugate targeting HER2/Neu antigen for diagnostic purposes.
    Moreau M; Raguin O; Vrigneaud JM; Collin B; Bernhard C; Tizon X; Boschetti F; Duchamp O; Brunotte F; Denat F
    Bioconjug Chem; 2012 Jun; 23(6):1181-8. PubMed ID: 22519915
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals.
    Ferreira CL; Yapp DT; Lamsa E; Gleave M; Bensimon C; Jurek P; Kiefer GE
    Nucl Med Biol; 2008 Nov; 35(8):875-82. PubMed ID: 19026949
    [TBL] [Abstract][Full Text] [Related]  

  • 63. ¹¹¹In-Bn-DTPA-nimotuzumab with/without modification with nuclear translocation sequence (NLS) peptides: an Auger electron-emitting radioimmunotherapeutic agent for EGFR-positive and trastuzumab (Herceptin)-resistant breast cancer.
    Fasih A; Fonge H; Cai Z; Leyton JV; Tikhomirov I; Done SJ; Reilly RM
    Breast Cancer Res Treat; 2012 Aug; 135(1):189-200. PubMed ID: 22736376
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Improved synthesis of the bifunctional chelator p-SCN-Bn-HOPO.
    Bhupathiraju NVSDK; Younes A; Cao M; Ali J; Cicek HT; Tully KM; Ponnala S; Babich JW; Deri MA; Lewis JS; Francesconi LC; Drain CM
    Org Biomol Chem; 2019 Jul; 17(28):6866-6871. PubMed ID: 31268109
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Evaluation of the serum stability and in vivo biodistribution of CHX-DTPA and other ligands for yttrium labeling of monoclonal antibodies.
    Camera L; Kinuya S; Garmestani K; Wu C; Brechbiel MW; Pai LH; McMurry TJ; Gansow OA; Pastan I; Paik CH
    J Nucl Med; 1994 May; 35(5):882-9. PubMed ID: 8176477
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Micro-SPECT/CT with 111In-DTPA-pertuzumab sensitively detects trastuzumab-mediated HER2 downregulation and tumor response in athymic mice bearing MDA-MB-361 human breast cancer xenografts.
    McLarty K; Cornelissen B; Cai Z; Scollard DA; Costantini DL; Done SJ; Reilly RM
    J Nucl Med; 2009 Aug; 50(8):1340-8. PubMed ID: 19617342
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physical parameters and biological stability of yttrium(III) diethylenetriaminepentaacetic acid derivative conjugates.
    McMurry TJ; Pippin CG; Wu C; Deal KA; Brechbiel MW; Mirzadeh S; Gansow OA
    J Med Chem; 1998 Aug; 41(18):3546-9. PubMed ID: 9719608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
    Sabbah EN; Kadouche J; Ellison D; Finucane C; Decaudin D; Mather SJ
    Nucl Med Biol; 2007 Apr; 34(3):293-304. PubMed ID: 17383579
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution.
    Dearling JL; Paterson BM; Akurathi V; Betanzos-Lara S; Treves ST; Voss SD; White JM; Huston JS; Smith SV; Donnelly PS; Packard AB
    Bioconjug Chem; 2015 Apr; 26(4):707-17. PubMed ID: 25719414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Phase I trial of intraoperative detection of tumor margins in patients with HER2-positive carcinoma of the breast following administration of 111In-DTPA-trastuzumab Fab fragments.
    Holloway CM; Scollard DA; Caldwell CB; Ehrlich L; Kahn HJ; Reilly RM
    Nucl Med Biol; 2013 Jul; 40(5):630-7. PubMed ID: 23618841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Multifunctional Desferrichrome Analogues as Versatile
    Adams CJ; Wilson JJ; Boros E
    Mol Pharm; 2017 Aug; 14(8):2831-2842. PubMed ID: 28665620
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design of immunogens: The effect of bifunctional chelator on immunological response to chelated copper.
    Zhu X; Miao X; Qin X; Zhu X
    J Pharm Biomed Anal; 2019 Sep; 174():263-269. PubMed ID: 31181489
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of (111)In-labeled macrocyclic chelator-amino acid derivatives for cancer imaging.
    Lee JJ; Shetty D; Lee YS; Kim SE; Kim YJ; Hong MK; Son JY; Jeong JM
    Nucl Med Biol; 2012 Apr; 39(3):325-33. PubMed ID: 22136890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals.
    Cai H; Li Z; Huang CW; Park R; Shahinian AH; Conti PS
    Nucl Med Biol; 2010 Jan; 37(1):57-65. PubMed ID: 20122669
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies.
    Wilbur DS; Chyan MK; Hamlin DK; Kegley BB; Nilsson R; Sandberg BE; Brechbiel M
    Bioconjug Chem; 2002; 13(5):1079-92. PubMed ID: 12236790
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Preparation, quality control, and biodistribution assessment of [
    Abbas Abadi S; Alirezapour B; Kertész I; Rasaee MJ; Mohammadnejad J; Paknejad M; Yousefnia H; Zolghadri S
    J Labelled Comp Radiopharm; 2021 Apr; 64(4):168-180. PubMed ID: 33269473
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Linear Desferrichrome-Linked Silicon-Rhodamine Antibody Conjugate Enables Targeted Multimodal Imaging of HER2 in Vitro and in Vivo.
    Ahn SH; Thach D; Vaughn BA; Alford VM; Preston AN; Laughlin ST; Boros E
    Mol Pharm; 2019 Mar; 16(3):1412-1420. PubMed ID: 30714739
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [
    Toàn NM; Vágner A; Nagy G; Ország G; Nagy T; Csikos C; Váradi B; Sajtos GZ; Kapus I; Szoboszlai Z; Szikra D; Trencsényi G; Tircsó G; Garai I
    J Med Chem; 2024 May; 67(10):8261-8270. PubMed ID: 38690886
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.
    Burvenich IJ; Parakh S; Gan HK; Lee FT; Guo N; Rigopoulos A; Lee ST; Gong S; O'Keefe GJ; Tochon-Danguy H; Kotsuma M; Hasegawa J; Senaldi G; Scott AM
    J Nucl Med; 2016 Jun; 57(6):974-80. PubMed ID: 26940768
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of chelate conjugation on a newly identified tumor-targeting peptide.
    Mier W; Zitzmann S; Krämer S; Reed J; Knapp EM; Altmann A; Eisenhut M; Haberkorn U
    J Nucl Med; 2007 Sep; 48(9):1545-52. PubMed ID: 17704241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.